AONC (American Oncology Network) Momentum Rank : 0 (As of Dec. 12, 2024)

View and export this data going back to 2023. Start your Free Trial

What is American Oncology Network Momentum Rank?

American Oncology Network has the Momentum Rank of 0.

For Momentum Rank, we considered the residual momentum concept that was widely studied by Blitz and his colleagues as well as by Nobel Prize laureates Fama and French. However, we did not find any significant differences in the performances of stocks with different ranks of residual momentum. Therefore, we use traditional momentum instead.

Momentum Rank is determined using the standardized momentum ratio and other momentum indicators. The standardized momentum ratio is the average of the performances from 12 months ago to 1 month ago and 6 months ago to 1 month ago, divided by the beta of the stock over the past 12 months. To calculate the momentum ratio today, we would use the average of the two performance numbers.

For momentum, we found that stock price performance does not have a monotonic correlation with the momentum ratio. The stocks with the highest momentum ratios perform worse than those at about the 70th percentile. Therefore, for the momentum rank, we ranked the stocks at about the 70th percentile of the momentum ratio as the highest at 10.

Please click GF Score to see more details on the GF Score's 5 Key Aspects of Analysis.

American Oncology Network Momentum Rank Related Terms

Thank you for viewing the detailed overview of American Oncology Network's Momentum Rank provided by GuruFocus.com. Please click on the following links to see related term pages.

American Oncology Network Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » American Oncology Network Inc (OTCPK:AONC) » Definitions » Momentum Rank

Comparable Companies

Traded in Other Exchanges

N/A

Address

14543 Global Parkway, Suite 110, Fort Myers, FL, USA, 33913

Website

https://www.aoncology.com

American Oncology Network Inc is an alliance of physicians and seasoned healthcare leaders partnering to ensure the long-term success and viability of community oncology and other specialties. The company pioneers healthcare solutions through its physician-led model, fostering value-based care that improves patient outcomes while reducing costs and expanding access to quality care. It is committed to promoting health equity by addressing disparities in cancer care and ensuring that all patients have access to the care needed to achieve optimal health outcomes.

Executives

Stephen Divers	director, officer: Chief Medical Officer	133 HARMONY PARK CIRCLE, HOT SPRINGS AZ 71913
Todd Schonherz	director, officer: Chief Executive Officer	14543 GLOBAL PARKWAY, 2ND FLOOR, FORT MEYERS FL 33913
Saba Capital Management, L.p.	10 percent owner	405 LEXINGTON AVENUE, 58TH FLOOR, NEW YORK NY 10174
Boaz Weinstein	10 percent owner	405 LEXINGTON AVENUE, 58TH FLOOR, NEW YORK NY 10174
David H Gould	officer: Chief Financial Officer	7370 COLLEGE PARKWAY, SUITE 207, FORT MEYERS FL 33907
Erica Mallon	officer: General Counsel	14543 GLOBAL PARKWAY, SUITE 110, FORT MEYERS FL 33913
Shalin Shah	director	3402 W DR. MARTIN LUTHER KING JR. BLVD, TAMPA FL 33607
Vipul M Patel	director	11704 SE 15TH CIRCLE, OCALA FL 34480
Vance Wright-browne	director	22395 EDGEWATER DRIVE, PORT CHARLOTTE FL 33980
James Stith	director	ONE LETTERMAN DRIVE, CM200, SAN FRANCISCO CA 94129
Aea Growth Equity Fund Lp	10 percent owner	520 MADISON AVE, 40TH FLOOR, NEW YORK NY 10022
Aea Growth Equity Fund (parallel) Lp	10 percent owner	520 MADISON AVE, 40TH FLOOR, NEW YORK NY 10022
Ravi Yang Sarin	director	C/O ARES MANAGEMENT LLC, 2000 AVENUE OF THE STARS, 12TH FLOOR, LOS ANGELES CA 90067
Brian R Hoesterey	10 percent owner	C/O AEA INVESTORS LP, 666 FIFTH AVENUE, 36TH FLOOR, NEW YORK NY 10103
Kevin Nazemi	director, officer: Chief Executive Officer	10485 NE 6TH ST, UNIT 3930, BELLEVUE WA 98004